XOMA (XOMA Royalty) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XOMA XOMA Royalty Corp XOMA
41 GF Score
Price $40.17
GF Value $18.93
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is XOMA Royalty FFO?

FFO (Funds from operations) only applies to REITs.

XOMA
41GF Score
XOMA Royalty Corp XOMA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is XOMA Royalty (XOMA) Overvalued in 2026?

Based on GuruFocus' analysis, XOMA Royalty stock appears to be overvalued. The current stock price of $40.17 is trading 112.2% above its estimated GF Value™ of $18.93. GuruFocus considers XOMA Royalty to be Significantly Overvalued.

Key valuation signals for XOMA:

  • FFO:
  • GF Value™: $18.93 vs. price of $40.17 (112.2% above fair value)
  • GF Score™: 41/100 with 8 warning signs

No single metric tells the full story. See the XOMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

XOMA Royalty Business Description

Address 2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.
41GF Score

Get the complete analysis for XOMA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$40.17
Price
$18.93
GF Value